Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126673441 | 12667344 | 1 | I | 2016 | 20160810 | 20160819 | 20160819 | EXP | FR-INDIVIOR LIMITED-INDV-093758-2016 | INDIVIOR | 43.00 | YR | M | Y | 0.00000 | 20160819 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126673441 | 12667344 | 1 | PS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | U | U | UNKNOWN | 20732 | SUBLINGUAL TABLET | ||||||
| 126673441 | 12667344 | 2 | SS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | U | U | UNKNOWN | 20732 | SUBLINGUAL TABLET | ||||||
| 126673441 | 12667344 | 3 | SS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 10 MG, UNK (CURRENTLY RECEIVED) | U | U | UNKNOWN | 20732 | 10 | MG | SUBLINGUAL TABLET | ||||
| 126673441 | 12667344 | 4 | SS | COCAINE | COCAINE | 1 | Unknown | UNK | U | U | UNKNOWN | 0 | |||||||
| 126673441 | 12667344 | 5 | SS | COCAINE | COCAINE | 1 | Intravenous (not otherwise specified) | AT 2 G DAILY, 3 DAYS ON 5 DAYS | U | U | UNKNOWN | 0 | |||||||
| 126673441 | 12667344 | 6 | SS | COCAINE | COCAINE | 1 | Intravenous (not otherwise specified) | AT 0.5 G DAILY. | U | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126673441 | 12667344 | 1 | Product used for unknown indication |
| 126673441 | 12667344 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126673441 | 12667344 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126673441 | 12667344 | Dermatitis | |
| 126673441 | 12667344 | Drug dependence | |
| 126673441 | 12667344 | Erysipelas | |
| 126673441 | 12667344 | Intentional product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126673441 | 12667344 | 1 | 1996 | 0 | ||
| 126673441 | 12667344 | 2 | 2016 | 0 | ||
| 126673441 | 12667344 | 3 | 201607 | 0 | ||
| 126673441 | 12667344 | 5 | 201510 | 0 | ||
| 126673441 | 12667344 | 6 | 201606 | 0 |